Ramgopal Rao

CEO, LensGen, Inc.


Ram is a serial entrepreneur with 25 years of experience in the ophthalmic pharmaceutical and device industry.

Ram is the inventor, founder, and chief executive officer of LensGen, Inc., a clinical stage medical device company that is developing a novel intraocular lens for presbyopia. The company has received support from one of the largest medical device companies in the world. LensGen closed a $28.0 million Series A Financing in May 2018.

Currently, he is also Chairman of the Board of 2C Tech Corporation, Inc., an emerging medical device company that is developing a novel nanotechnology application for preservation of vision for patients with degenerative retinal diseases. 2C Tech Completed Series B Financing in 2016 and 2019.

Ram co-developed an innovative corneal implant device for presbyopia and licensed the technology to venture-funded Acufocus, Inc. The company is now commercializing the product on a global scale.

Prior to that, Ram founded Tomey Technology Inc., that pioneered the corneal topography imaging technology that is now a standard of care in eye care for LASIK and cataract surgery. This joint venture company was acquired by Tomey Corporation of Japan.

He was Chief Operating Officer and Director of Vitreoretinal Technologies, Inc., a venture-funded ophthalmic pharmaceutical company that developed a drug for diabetic retinopathy.

Ram was President of Ophthalmic Group at Premier Laser Systems, Inc.; a publicly held company that developed the first laser assisted cataract surgery technology. He also held various executive positions at Biorad Laboratories, Inc.